Mathematical Modeling of MPNs Offers Understanding and Decision Support for Personalized Treatment.
JAK2V617F dynamics
blood cancer
mathematical modeling
myeloproliferative neoplasms
personalized treatment
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Jul 2020
30 Jul 2020
Historique:
received:
27
06
2020
revised:
28
07
2020
accepted:
28
07
2020
entrez:
6
8
2020
pubmed:
6
8
2020
medline:
6
8
2020
Statut:
epublish
Résumé
(1) Background: myeloproliferative neoplasms (MPNs) are slowly developing hematological cancers characterized by few driver mutations, with
Identifiants
pubmed: 32751766
pii: cancers12082119
doi: 10.3390/cancers12082119
pmc: PMC7466162
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Blood. 2013 Aug 8;122(6):893-901
pubmed: 23782935
Blood. 2013 Aug 22;122(8):1395-8
pubmed: 23838352
Eur J Haematol. 2017 Jan;98(1):85-93
pubmed: 27500783
J Clin Oncol. 2011 Jun 10;29(17):2410-5
pubmed: 21537037
Cancer Med. 2020 Mar;9(6):2039-2051
pubmed: 31991066
Cell Mol Immunol. 2012 Jan;9(1):11-9
pubmed: 22020068
Math Biosci Eng. 2019 Sep 16;16(6):8268-8289
pubmed: 31698667
J Clin Oncol. 2005 Apr 1;23(10):2224-32
pubmed: 15710945
J Theor Biol. 2017 Jul 21;425:43-52
pubmed: 28501635
Am J Hematol. 2014 Jun;89(6):581-7
pubmed: 24971434
Annu Rev Immunol. 2004;22:329-60
pubmed: 15032581
Oncotarget. 2013 Apr;4(4):500-1
pubmed: 23660238
Blood. 2006 Sep 15;108(6):2037-40
pubmed: 16709929
Aliment Pharmacol Ther. 2007 Aug 1;26(3):369-76
pubmed: 17635371
PLoS One. 2017 Aug 31;12(8):e0183620
pubmed: 28859112
Blood. 2013 May 2;121(18):3692-702
pubmed: 23487027
Curr Hematol Malig Rep. 2014 Dec;9(4):340-9
pubmed: 25129052
Blood. 2017 Mar 23;129(12):1607-1616
pubmed: 28159736
Lancet Haematol. 2017 Apr;4(4):e165-e175
pubmed: 28291640
Oncoimmunology. 2013 Jun 1;2(6):e24572
pubmed: 23894719
J Exp Med. 2014 Feb 10;211(2):245-62
pubmed: 24493802
J Theor Biol. 2019 Mar 21;465:90-108
pubmed: 30615883
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16616-21
pubmed: 19805346
N Engl J Med. 2006 Dec 7;355(23):2452-66
pubmed: 17151367
Nature. 2005 Jun 30;435(7046):1267-70
pubmed: 15988530
Leukemia. 2016 Apr;30(4):776-81
pubmed: 26601783
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9857-60
pubmed: 7937905
Stem Cells. 2006 Dec;24(12):2603-10
pubmed: 16931775
Cell. 2008 Feb 22;132(4):631-44
pubmed: 18295580
Cancer Res. 2015 Mar 15;75(6):940-9
pubmed: 25614516
Nat Rev Cancer. 2010 Mar;10(3):221-30
pubmed: 20179714
Nat Rev Cancer. 2015 Dec;15(12):730-45
pubmed: 26597528
Math Biosci. 2020 Aug;326:108372
pubmed: 32442449
Blood. 2013 Jun 6;121(23):4778-81
pubmed: 23591792
Drugs. 2010;70(2):147-65
pubmed: 20108989
Exp Hematol. 2015 Oct;43(10):912-918.e2
pubmed: 26072330
PeerJ. 2020 Apr 8;8:e8842
pubmed: 32296600
Blood. 2011 Aug 11;118(6):1622-31
pubmed: 21653938
Lancet Haematol. 2020 Mar;7(3):e196-e208
pubmed: 32014125
Drug Metab Pharmacokinet. 2012;27(6):614-20
pubmed: 22785255
Leukemia. 2004 Feb;18(2):309-15
pubmed: 14671645